ID: ALA278293

Max Phase: Preclinical

Molecular Formula: C27H22N2O5

Molecular Weight: 454.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1cc(-c2ccoc2)c2ccc(OCc3cccc(C4(O)CC5COC(C4)O5)n3)cc2c1

Standard InChI:  InChI=1S/C27H22N2O5/c28-13-17-8-19-10-21(4-5-23(19)24(9-17)18-6-7-31-14-18)32-15-20-2-1-3-25(29-20)27(30)11-22-16-33-26(12-27)34-22/h1-10,14,22,26,30H,11-12,15-16H2

Standard InChI Key:  LBKHEHIDDIEBSX-UHFFFAOYSA-N

Associated Targets(Human)

ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovis aries (854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.48Molecular Weight (Monoisotopic): 454.1529AlogP: 4.67#Rotatable Bonds: 5
Polar Surface Area: 97.74Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.19CX Basic pKa: 3.15CX LogP: 3.92CX LogD: 3.92
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.47Np Likeness Score: -0.03

References

1. Dubé D, Blouin M, Brideau C, Chan CC, Desmarais S, Ethier D, Falgueyret JP, Friesen RW, Girard M, Girard Y, Guay J, Riendeau D, Tagari P, Young RN..  (1998)  Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.,  (10): [PMID:9871745] [10.1016/s0960-894x(98)00201-7]
2. Hamel P, Riendeau D, Brideau C, Chan CC, Desmarais S, Delorme D, Dubé D, Ducharme Y, Ethier D, Grimm E, Falgueyret JP, Guay J, Jones TR, Kwong E, McAuliffe M, McFarlane CS, Piechuta H, Roumi M, Tagari P, Young RN, Girard Y..  (1997)  Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.,  40  (18): [PMID:9288168] [10.1021/jm970046b]
3. Wu YJ, Meanwell NA..  (2021)  Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.,  64  (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790]

Source